Positive Topline Results from Phase III Trial of Batoclimab for Treatment of Generalized Myasthenia Gravis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, March 6, 2023. Harbour BioMed (the " Company " ), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - March 6, 2023 Category: Pharmaceuticals Source Type: clinical trials
Study of Telitacicept in Generalized Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized Interventions: Biological: Telitacicept; Drug: Placebo Sponsor: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 21, 2023 Category: Research Source Type: clinical trials
Open-Label Extension of Tocilizumab in Subjects With Generalized Myasthenia Gravis
Condition: Myasthenia Gravis, Generalized Intervention: Drug: Tocilizumab Injection Sponsor: Tang-Du Hospital Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials
